É. Luporsi - Concepedia

Author

É. Luporsi

Délégation Centre-Est

Also Known As

Achard JL, E Luporsi, E. Luporsi, Elisabeth Luporsi, Elisabethe Luporsi, Luporsi E., Luporsi, E., É Luporsi, É. Luporsi

127

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Délégation Centre-Est Institut Gustave Roussy Centre Oscar Lambret Hôpital René Huguenin Centre Eugène Marquis

ÉL

About

É. Luporsi is an author at Délégation Centre-Est specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	1.2K
2	Health Sciences	9	9	289
3	Public Health	3	3	88
4	Biostatistics	1	1	197
5	Epidemiology	1	1	17

É. Luporsi

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial Hervé Bonnefoi, Saskia Litière, Martine Piccart, Annals of Oncology Breast OncologyEortc 10994/BigMedicinePathologyPathological Complete Response	2014	197
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial Xavier Pivot, Gilles Romieu, Marc Debled, The Lancet Breast OncologyOncologyEarly Breast CancerRandomised TrialBreast Cancer	2019	125
Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results P. Fumoleau, Henri Roché, Pierre Kerbrat, Annals of Oncology Adjuvant Epirubicin-based ChemotherapyBreast OncologyOncologyEarly Breast CancerMedicine	2005	108
High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study D. Peiffert, Marc Giovannini, Michel Ducreux, Annals of Oncology Surgical OncologyHigh-dose Radiation TherapyRadiation TherapyMedicineConcomitant Chemotherapy	2001	99
French version of FACT-G: validation and comparison with other cancer-specific instruments Thierry Conroy, M. Mercier, Jacques Bonneterre, European Journal of Cancer Surgical OncologyFrench VersionMedicineCancer ManagementEpidemiology Of Cancer	2004	78
Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas Valérie Bernier‐Chastagner, Jacques Grill, François Doz, Cancer	2005	75
Brachytherapy for lower lip epidermoid cancer: tumoral and treatment factors influencing recurrences and complications Sylvie Beauvois, S. Hoffstetter, D. Peiffert, Radiotherapy and Oncology Surgical OncologyMedicineBrachytherapyBreast CancerTreatment Factors	1994	71
Role of Interstitial Brachytherapy in Oral and Oropharyngeal Carcinoma: Reflection of a Series of 1344 Patients Treated at the Time of Initial Presentation M Pernot, S. Hoffstetter, D. Peiffert, Otolaryngology External-beam IrradiationSurgical OncologyHealth SciencesRadiation TherapyInterstitial Brachytherapy	1996	67
A Multicenter Phase II Study with Triptorelin (Sustained-Release LHRH Agonist) in Advanced or Recurrent Endometrial Carcinoma: A French Anticancer Federation Study C. Lhommé, P Vennin, Nasrine Callet, Gynecologic Oncology Endocrine-related CancerMedicinePharmacologyGynecologyPharmacotherapy	1999	48
Velotonsillar squamous cell carcinoma: 277 cases treated by combined external irradiation and brachytherapy-results according to extension, localization, and dose rate M Pernot, L Malissard, Alphonse G. Taghian, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyRadiation TherapyMedicineBrachytherapyCombined External Irradiation	1992	47

Page 1